Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Neuromodulation and Neurostimulation Pain Management Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Neuromodulation and Neurostimulation Pain Management Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Neuromodulation and Neurostimulation Pain Management Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-01-19

Pages: 97 Pages

Report ld: 5744861

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Neuromodulation and Neurostimulation Pain Management Devices was estimated to be worth US$ 2396 million in 2025 and is projected to reach US$ 3686 million, growing at a CAGR of 6.4% from 2026 to 2032.

Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.

Neuromodulation and Neurostimulation Pain Management Devices Market Size(US$)

M= millions and B=billions

QYRLogo
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.

This report provides a comprehensive view of the global market for Neuromodulation and Neurostimulation Pain Management Devices, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Neuromodulation and Neurostimulation Pain Management Devices market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Neuromodulation and Neurostimulation Pain Management Devices.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Neuromodulation and Neurostimulation Pain Management Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  • Forecasted Market Size in 2032

  • US$ 3686 million

  • CAGR(2026-2032)

  • 6.4%

  • Market Size Available for Years

  • 2026-2032

  • Global Neuromodulation and Neurostimulation Pain Management Devices Companies Covered

  • Medtronic Plc

    Boston Scientific Corporation

    Pfizer Inc. (Hospira Inc.)

    Johnson & Johnson (Codman And Shurtleff, Inc.)

    Stryker Corporation

    Kimberly-Clark Corporation (Baylis Medical)

    Colfax Corporation (Djo Global Llc)

    Abbott Laboratories

    B Braun Melsungen Ag

    Baxter International Inc.

  • Global Neuromodulation and Neurostimulation Pain Management Devices Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Neuromodulation and Neurostimulation Pain Management Devices Market, Segment by Type

  • Spinal Cord Stimulators

    Transcutaneous Electrical Nerve Stimulation (TENS) Devices

  • Global Neuromodulation and Neurostimulation Pain Management Devices Market, Segment by Application

  • Neuropathic Pain

    Cancer Pain

    Facial & Migraine Pain

    Musculoskeletal Pain

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Neuromodulation and Neurostimulation Pain Management Devices companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Neuromodulation and Neurostimulation Pain Management Devices revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Neuromodulation and Neurostimulation Pain Management Devices revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Neuromodulation and Neurostimulation Pain Management Devices Product Introduction
    1.2 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Forecast (2021–2032)
    1.3 Neuromodulation and Neurostimulation Pain Management Devices Market Trends & Drivers
        1.3.1 Neuromodulation and Neurostimulation Pain Management Devices Industry Trends
        1.3.2 Neuromodulation and Neurostimulation Pain Management Devices Market Drivers & Opportunities
        1.3.3 Neuromodulation and Neurostimulation Pain Management Devices Market Challenges
        1.3.4 Neuromodulation and Neurostimulation Pain Management Devices Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Players Revenue Ranking (2025)
    2.2 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Neuromodulation and Neurostimulation Pain Management Devices Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Neuromodulation and Neurostimulation Pain Management Devices
    2.6 Neuromodulation and Neurostimulation Pain Management Devices Market Competitive Analysis
        2.6.1 Neuromodulation and Neurostimulation Pain Management Devices Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Neuromodulation and Neurostimulation Pain Management Devices Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neuromodulation and Neurostimulation Pain Management Devices revenue, 2025
    2.7 Mergers & Acquisitions and Expansion
3 Segmentation Neuromodulation and Neurostimulation Pain Management Devices Market Classification
    3.1 Introduction by Type
        3.1.1 Spinal Cord Stimulators
        3.1.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
        3.1.3 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type
            3.1.3.1 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value, by Type (2021–2032)
            3.1.3.3 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Neuropathic Pain
        4.1.2 Cancer Pain
        4.1.3 Facial & Migraine Pain
        4.1.4 Musculoskeletal Pain
        4.1.5 Others
    4.2 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application
        4.2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (2021–2032)
        4.2.3 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2021–2032
5 Segmentation by Region
    5.1 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region
        5.1.1 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (2021–2026)
        5.1.3 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (2027–2032)
        5.1.4 Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        5.2.2 North America Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        5.3.2 Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        5.4.2 Asia Pacific Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        5.5.2 South America Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        5.6.2 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Neuromodulation and Neurostimulation Pain Management Devices Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.3.2 United States Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.4.2 Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.5.2 China Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.6.2 Japan Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.7.2 South Korea Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.8.2 Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021–2032
        6.9.2 India Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 Medtronic Plc
        7.1.1 Medtronic Plc Profile
        7.1.2 Medtronic Plc Main Business
        7.1.3 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.1.4 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.1.5 Medtronic Plc Recent Developments
    7.2 Boston Scientific Corporation
        7.2.1 Boston Scientific Corporation Profile
        7.2.2 Boston Scientific Corporation Main Business
        7.2.3 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.2.4 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.2.5 Boston Scientific Corporation Recent Developments
    7.3 Pfizer Inc. (Hospira Inc.)
        7.3.1 Pfizer Inc. (Hospira Inc.) Profile
        7.3.2 Pfizer Inc. (Hospira Inc.) Main Business
        7.3.3 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.3.4 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.3.5 Pfizer Inc. (Hospira Inc.) Recent Developments
    7.4 Johnson & Johnson (Codman And Shurtleff, Inc.)
        7.4.1 Johnson & Johnson (Codman And Shurtleff, Inc.) Profile
        7.4.2 Johnson & Johnson (Codman And Shurtleff, Inc.) Main Business
        7.4.3 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.4.4 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.4.5 Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Developments
    7.5 Stryker Corporation
        7.5.1 Stryker Corporation Profile
        7.5.2 Stryker Corporation Main Business
        7.5.3 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.5.4 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.5.5 Stryker Corporation Recent Developments
    7.6 Kimberly-Clark Corporation (Baylis Medical)
        7.6.1 Kimberly-Clark Corporation (Baylis Medical) Profile
        7.6.2 Kimberly-Clark Corporation (Baylis Medical) Main Business
        7.6.3 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.6.4 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.6.5 Kimberly-Clark Corporation (Baylis Medical) Recent Developments
    7.7 Colfax Corporation (Djo Global Llc)
        7.7.1 Colfax Corporation (Djo Global Llc) Profile
        7.7.2 Colfax Corporation (Djo Global Llc) Main Business
        7.7.3 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.7.4 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.7.5 Colfax Corporation (Djo Global Llc) Recent Developments
    7.8 Abbott Laboratories
        7.8.1 Abbott Laboratories Profile
        7.8.2 Abbott Laboratories Main Business
        7.8.3 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.8.4 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.8.5 Abbott Laboratories Recent Developments
    7.9 B Braun Melsungen Ag
        7.9.1 B Braun Melsungen Ag Profile
        7.9.2 B Braun Melsungen Ag Main Business
        7.9.3 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.9.4 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.9.5 B Braun Melsungen Ag Recent Developments
    7.10 Baxter International Inc.
        7.10.1 Baxter International Inc. Profile
        7.10.2 Baxter International Inc. Main Business
        7.10.3 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
        7.10.4 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million), 2021–2026
        7.10.5 Baxter International Inc. Recent Developments
8 Industry Chain Analysis
    8.1 Neuromodulation and Neurostimulation Pain Management Devices Value Chain
    8.2 Neuromodulation and Neurostimulation Pain Management Devices Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Neuromodulation and Neurostimulation Pain Management Devices Sales Model
        8.5.2 Sales Channels
        8.5.3 Neuromodulation and Neurostimulation Pain Management Devices Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Neuromodulation and Neurostimulation Pain Management Devices Market Trends
 Table 2. Neuromodulation and Neurostimulation Pain Management Devices Market Drivers & Opportunities
 Table 3. Neuromodulation and Neurostimulation Pain Management Devices Market Challenges
 Table 4. Neuromodulation and Neurostimulation Pain Management Devices Market Restraints
 Table 5. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Neuromodulation and Neurostimulation Pain Management Devices Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Neuromodulation and Neurostimulation Pain Management Devices
 Table 10. Global Neuromodulation and Neurostimulation Pain Management Devices Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neuromodulation and Neurostimulation Pain Management Devices revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (US$ Million), 2021–2026
 Table 20. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (US$ Million), 2027–2032
 Table 21. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Market Share in Value by Application (2021–2026)
 Table 22. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Market Share in Value by Application (2027–2032)
 Table 23. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 24. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (US$ Million), 2021–2026
 Table 25. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (US$ Million), 2027–2032
 Table 26. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (%), 2021–2026
 Table 27. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Region (%), 2027–2032
 Table 28. Key Countries/Regions Neuromodulation and Neurostimulation Pain Management Devices Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 29. Key Countries/Regions Neuromodulation and Neurostimulation Pain Management Devices Sales Value, (US$ Million), 2021–2026
 Table 30. Key Countries/Regions Neuromodulation and Neurostimulation Pain Management Devices Sales Value, (US$ Million), 2027–2032
 Table 31. Medtronic Plc Basic Information List
 Table 32. Medtronic Plc Description and Business Overview
 Table 33. Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 34. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Medtronic Plc (2021–2026)
 Table 35. Medtronic Plc Recent Developments
 Table 36. Boston Scientific Corporation Basic Information List
 Table 37. Boston Scientific Corporation Description and Business Overview
 Table 38. Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 39. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Boston Scientific Corporation (2021–2026)
 Table 40. Boston Scientific Corporation Recent Developments
 Table 41. Pfizer Inc. (Hospira Inc.) Basic Information List
 Table 42. Pfizer Inc. (Hospira Inc.) Description and Business Overview
 Table 43. Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Pfizer Inc. (Hospira Inc.) (2021–2026)
 Table 45. Pfizer Inc. (Hospira Inc.) Recent Developments
 Table 46. Johnson & Johnson (Codman And Shurtleff, Inc.) Basic Information List
 Table 47. Johnson & Johnson (Codman And Shurtleff, Inc.) Description and Business Overview
 Table 48. Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Johnson & Johnson (Codman And Shurtleff, Inc.) (2021–2026)
 Table 50. Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Developments
 Table 51. Stryker Corporation Basic Information List
 Table 52. Stryker Corporation Description and Business Overview
 Table 53. Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Stryker Corporation (2021–2026)
 Table 55. Stryker Corporation Recent Developments
 Table 56. Kimberly-Clark Corporation (Baylis Medical) Basic Information List
 Table 57. Kimberly-Clark Corporation (Baylis Medical) Description and Business Overview
 Table 58. Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Kimberly-Clark Corporation (Baylis Medical) (2021–2026)
 Table 60. Kimberly-Clark Corporation (Baylis Medical) Recent Developments
 Table 61. Colfax Corporation (Djo Global Llc) Basic Information List
 Table 62. Colfax Corporation (Djo Global Llc) Description and Business Overview
 Table 63. Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Colfax Corporation (Djo Global Llc) (2021–2026)
 Table 65. Colfax Corporation (Djo Global Llc) Recent Developments
 Table 66. Abbott Laboratories Basic Information List
 Table 67. Abbott Laboratories Description and Business Overview
 Table 68. Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Abbott Laboratories (2021–2026)
 Table 70. Abbott Laboratories Recent Developments
 Table 71. B Braun Melsungen Ag Basic Information List
 Table 72. B Braun Melsungen Ag Description and Business Overview
 Table 73. B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of B Braun Melsungen Ag (2021–2026)
 Table 75. B Braun Melsungen Ag Recent Developments
 Table 76. Baxter International Inc. Basic Information List
 Table 77. Baxter International Inc. Description and Business Overview
 Table 78. Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Baxter International Inc. (2021–2026)
 Table 80. Baxter International Inc. Recent Developments
 Table 81. Revenue (US$ Million) in Neuromodulation and Neurostimulation Pain Management Devices Business of Company 40 (2021–2026)
 Table 82. Company 40 Recent Developments
 Table 83. Key Raw Materials Lists
 Table 84. Key Suppliers of Raw Materials Lists
 Table 85. Neuromodulation and Neurostimulation Pain Management Devices Downstream Customers
 Table 86. Neuromodulation and Neurostimulation Pain Management Devices Distributors List
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources


List of Figures
 Figure 1. Neuromodulation and Neurostimulation Pain Management Devices Product Picture
 Figure 2. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 4. Neuromodulation and Neurostimulation Pain Management Devices Report Years Considered
 Figure 5. Global Neuromodulation and Neurostimulation Pain Management Devices Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Neuromodulation and Neurostimulation Pain Management Devices Revenue in 2025
 Figure 7. Neuromodulation and Neurostimulation Pain Management Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Spinal Cord Stimulators Picture
 Figure 9. Transcutaneous Electrical Nerve Stimulation (TENS) Devices Picture
 Figure 10. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value Market Share by Type, 2025 & 2032
 Figure 12. Product Picture of Neuropathic Pain
 Figure 13. Product Picture of Cancer Pain
 Figure 14. Product Picture of Facial & Migraine Pain
 Figure 15. Product Picture of Musculoskeletal Pain
 Figure 16. Product Picture of Others
 Figure 17. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Neuromodulation and Neurostimulation Pain Management Devices Sales Value Market Share by Application, 2025 & 2032
 Figure 19. North America Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 20. North America Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
 Figure 21. Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 22. Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
 Figure 23. Asia Pacific Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 24. Asia Pacific Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Subregion (%), 2025 vs 2032
 Figure 25. South America Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 26. South America Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
 Figure 27. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 28. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Country (%), 2025 vs 2032
 Figure 29. Key Countries/Regions Neuromodulation and Neurostimulation Pain Management Devices Sales Value (%), 2021–2032
 Figure 30. United States Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 31. United States Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 32. United States Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 33. Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 34. Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 35. Europe Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 36. China Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 37. China Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 38. China Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 39. Japan Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 40. Japan Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 41. Japan Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 42. South Korea Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 43. South Korea Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 44. South Korea Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 45. Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 46. Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 47. Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 48. India Neuromodulation and Neurostimulation Pain Management Devices Sales Value (US$ Million), 2021–2032
 Figure 49. India Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Type (%), 2025 vs 2032
 Figure 50. India Neuromodulation and Neurostimulation Pain Management Devices Sales Value by Application (%), 2025 vs 2032
 Figure 51. Neuromodulation and Neurostimulation Pain Management Devices Value Chain
 Figure 52. Neuromodulation and Neurostimulation Pain Management Devices Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed

Description

The global market for Neuromodulation and Neurostimulation Pain Management Devices was estimated to be worth US$ 2396 million in 2025 and is projected to reach US$ 3686 million, growing at a CAGR of 6.4% from 2026 to 2032.

Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.

This report provides a comprehensive view of the global market for Neuromodulation and Neurostimulation Pain Management Devices, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Neuromodulation and Neurostimulation Pain Management Devices market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Neuromodulation and Neurostimulation Pain Management Devices.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Neuromodulation and Neurostimulation Pain Management Devices companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Neuromodulation and Neurostimulation Pain Management Devices revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Neuromodulation and Neurostimulation Pain Management Devices revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Neuromodulation and Neurostimulation Pain Management Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-01-19

Pages: 97 Pages

Report ld: 5744861

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Offline

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Online

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Online

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Online

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Online

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Online

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now